SI | Sucrase-isomaltase (alpha-glucosidase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SLC5A11 | Solute carrier family 5 (sodium/inositol cotransporter), member 11 | Predicted membrane proteins
| | | | | Group enriched |
TREH | Trehalase (brush-border membrane glycoprotein) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
ATOH1 | Atonal homolog 1 (Drosophila) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Group enriched |
C8G | Complement component 8, gamma polypeptide | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CFC1B | Cripto, FRL-1, cryptic family 1B | Predicted secreted proteins
| | | | | Group enriched |
DAZ1 | Deleted in azoospermia 1 | Disease related genes
| | | | | Tissue enriched |
ENPP7 | Ectonucleotide pyrophosphatase/phosphodiesterase 7 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
FAM159B | Family with sequence similarity 159, member B | Predicted membrane proteins
| | | | | Group enriched |
GLTPD2 | Glycolipid transfer protein domain containing 2 | Predicted secreted proteins
| | | | | Group enriched |
GUCA2A | Guanylate cyclase activator 2A (guanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MUC6 | Mucin 6, oligomeric mucus/gel-forming | Predicted secreted proteins
| | | | | Group enriched |
PYY | Peptide YY | Predicted secreted proteins
| | | | | Group enriched |
SLC2A7 | Solute carrier family 2 (facilitated glucose transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A4 | Solute carrier family 5 (glucose activated ion channel), member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM236 | | Predicted membrane proteins
| | | | | Group enriched |
VSIG1 | V-set and immunoglobulin domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FAM151A | Family with sequence similarity 151, member A | | | | | | Group enriched |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
KCNJ13 | Potassium inwardly-rectifying channel, subfamily J, member 13 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
NXPE1 | Neurexophilin and PC-esterase domain family, member 1 | Predicted membrane proteins
| | | | | Group enriched |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
REP15 | RAB15 effector protein | | | | | | Group enriched |
RP11-77K12.7 | | | | | | | Group enriched |
S100G | S100 calcium binding protein G | | | | | | Tissue enriched |
SOAT2 | Sterol O-acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | | | | Group enriched |
APOBEC1 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 | | | | | | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CHST5 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CTSE | Cathepsin E | Enzymes Predicted secreted proteins
| | | | | Group enriched |
DAZ2 | Deleted in azoospermia 2 | Disease related genes
| | | | | Tissue enriched |
DAZ3 | Deleted in azoospermia 3 | Disease related genes
| | | | | Tissue enriched |
DHRS11 | Dehydrogenase/reductase (SDR family) member 11 | | | | | | Group enriched |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins
| | | | | Group enriched |
GHRL | Ghrelin/obestatin prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KDM8 | Lysine (K)-specific demethylase 8 | Enzymes
| | | | | Group enriched |
NXPE4 | Neurexophilin and PC-esterase domain family, member 4 | Predicted secreted proteins
| | | | | Group enriched |
PRAP1 | Proline-rich acidic protein 1 | Predicted secreted proteins
| | | | | Group enriched |
SLC5A1 | Solute carrier family 5 (sodium/glucose cotransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM236 | Transmembrane protein 236 | Predicted membrane proteins
| | | | | Group enriched |
UGT1A10 | UDP glucuronosyltransferase 1 family, polypeptide A10 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
BARX1 | BARX homeobox 1 | Transcription factors
| | | | | Tissue enriched |
BEST2 | Bestrophin 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | | | | Group enriched |